Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Rev Neurol ; 78(4): 117-118, 2024 Feb 16.
Artículo en Español, Inglés | MEDLINE | ID: mdl-38349320

RESUMEN

TITLE: Hernia de disco gigante extruida que imita un absceso dentro del músculo psoas: una presentación poco común de una enfermedad común.


Asunto(s)
Absceso , Músculos Psoas , Humanos
2.
Breast ; 65: 145-150, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35970028

RESUMEN

BACKGROUND: HER2-positive breast cancers are rare amongst BRCA mutation carriers. No data exist regarding clinicopathological characteristics and prognosis of this subgroup of patients. MATERIALS AND METHODS: Using a retrospective matched cohort design, we collected data from 700 women who were diagnosed with operable invasive breast cancer from January 2006 to December 2016 and were screened for germline BRCA mutations. Clinicopathological features and survival rates were analyzed by BRCA and HER2 status. RESULTS: One hundred and fifteen HER2-positive/BRCA mutated cases were evaluated in comparison to the three control groups: HER2-positive/BRCA wild type (n = 129), HER2-negative/BRCA mutated (n = 222), HER2-negative/BRCA wild type (n = 234). HER2-positive breast cancers were more likely to have high histologic grade and high proliferation rate than HER2-negative neoplasms, regardless of BRCA mutation status. An interaction between BRCA mutations and HER2-positive status was found to correlate with worse survival after adjusting for prognostic variables (HR = 3.4; 95% CI: 1.3-16.7). CONCLUSIONS: Co-occurrence of BRCA mutations and HER2-positive status is a poor prognostic factor in patients with early or locally advanced breast cancer. This finding may be a proof of concept that a combined pharmacological intervention directed to these targets could be synergistic.


Asunto(s)
Neoplasias de la Mama , Neoplasias de la Mama/patología , Femenino , Células Germinativas/patología , Mutación de Línea Germinal , Humanos , Mutación , Pronóstico , Estudios Retrospectivos
3.
Breast ; 46: 19-24, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31051411

RESUMEN

BACKGROUND: Endocrine treatment with Tamoxifen and aromatase inhibitors (AIs) is a staple in the management of hormone receptor positive breast cancer (HR + BC). It has become clear that HR + BC carries a consistent risk of relapse up to 15 years post-diagnosis. While increasing evidence supports the use of extended adjuvant Tamoxifen over 5 years, controversial data are available on the optimal duration of extended AIs adjuvant treatment. We performed a meta-analysis to assess the real impact of extended adjuvant therapy with AIs on disease-free survival (DFS). METHODS: A literature-based meta-analysis of randomized controlled trials (RCTs) was undertaken. Relevant publications from PubMed, the Cochrane Library, and abstracts from American Society of Clinical Oncology (ASCO) and San Antonio Breast Cancer (SABCS) symposia were searched. Primary and secondary endpoints were Disease Free Survival (DFS) and overall survival (OS) respectively. A subgroup analysis was also performed to elucidate the impact of nodal involvement. RESULTS: The pooled analysis revealed a significant increase in DFS in the extended AIs group (hazard ratio (HR): 0.78, 95% CI: 0.68-0.90; P = 0.0006). The subgroup analysis according to nodal status showed a greater DFS benefit with extended AIs in patients with positive nodes (HR = 0.67 versus 0.80). Our analysis also demonstrated no improvement in OS with extended AIs (HR = 0.99, 95%CI: 0.87-1.12; P = 0.84). CONCLUSION: This work confirmed the efficacy of extended adjuvant treatment with AIs for HR + early breast cancer, with a 22% increase in DFS, but no impact on OS. Greater efficacy was observed in women with positive nodal status.


Asunto(s)
Antineoplásicos Hormonales/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Inhibidores de la Aromatasa/administración & dosificación , Neoplasias de la Mama/tratamiento farmacológico , Tamoxifeno/administración & dosificación , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/mortalidad , Quimioterapia Adyuvante , Supervivencia sin Enfermedad , Femenino , Humanos , Modelos de Riesgos Proporcionales , Ensayos Clínicos Controlados Aleatorios como Asunto , Receptor ErbB-2/metabolismo , Resultado del Tratamiento
4.
Clin Otolaryngol ; 43(2): 638-644, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29194991

RESUMEN

BACKGROUND: To report our experience of postoperative haemorrhage in patients following transoral robotic surgery (TORS). METHODS: Data were collected on patients having TORS. Postoperative haemorrhage within 30 days was graded using the Mayo Clinic grading system. RESULTS: Transoral robotic surgery operations were performed on 122 patients. There were 23 bleeding events classified as minor to severe following 19 operations (16%). Haemorrhage requiring a return to the operating room occurred after 7 operations (6%). The odds of an emergent haemorrhage were 5.19 times greater in patients who had a staged neck dissection after TORS (P = .05). The odds of a postoperative bleeding event were 2.6 times greater in patients receiving a larger resection (P = .107). There were no haemorrhage events in the 36 patients who received a synchronous neck dissection with transcervical ligation of the external carotid artery. CONCLUSIONS: Surgical intervention for TORS haemorrhage occurred in 6% patients. No haemorrhage occurred in patients who had ligation of the external carotid artery.


Asunto(s)
Carcinoma de Células Escamosas/cirugía , Neoplasias de la Boca/cirugía , Disección del Cuello/efectos adversos , Neoplasias de Oído, Nariz y Garganta/cirugía , Hemorragia Posoperatoria/epidemiología , Procedimientos Quirúrgicos Robotizados/efectos adversos , Anciano , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/patología , Estadificación de Neoplasias , Neoplasias de Oído, Nariz y Garganta/patología , Estudios Retrospectivos
5.
Theriogenology ; 97: 159-169, 2017 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-28583600

RESUMEN

To test the hypothesis that the administration of 2.5 mg of estradiol benzoate (EB) followed by 1500 mg of long acting progesterone (LA P4) causes similar uterine changes and molecular dynamics in anovulatory mares to those observed in cyclic ones, we evaluated the changes of estrogen (ERα and ERß) and progesterone receptors (PR) in anestrous, transitional and cyclic mares by RT-qPCR and immunohistochemistry. In addition, we evaluated uterine edema, tonus and estrogens and progesterone plasma profile. Endometrial biopsies were taken from anestrous and transitional mares immediately before EB injection, 48 h after EB administration and five days after LA P4 was given. In cyclic mares, biopsies were collected at estrus and at five days after ovulation. Similar estrogen peaks were achieved after the injection of the single EB dose between treated and cyclic groups, as well as maximum uterine edema. Uterine tone was increased to diestrus levels after administration of 1500 mg of LA P4. Changes in relative abundance of transcripts for PR, ERα and ERß when progesterone stimulated endometrium was compared to estrogen stimulated endometrium were similar between cyclic and non-cyclic treated mares. However, apparent decreased PR in the endometrial glandular epithelium was not observed in non-cyclic mares five days after LA P4 administration as observed at five days after ovulation in cyclic mares. The protocol produced similar endometrial edema, uterine tonus and changes in relative abundance of PR, ERα and ERß transcripts to those observed in cyclic mares during late estrus and early diestrus, as well as similar estradiol and estrogen conjugate plasma concentrations.


Asunto(s)
Estradiol/farmacología , Ciclo Estral/fisiología , Caballos/fisiología , Progesterona/farmacología , Útero/efectos de los fármacos , Animales , Estradiol/administración & dosificación , Femenino , Progesterona/administración & dosificación , Útero/fisiología
6.
Pharmacogenomics J ; 16(5): 472-7, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27378608

RESUMEN

Lapatinib enhances antibody-dependent cell-mediated cytotoxicity (ADCC) activity of trastuzumab. FcγR polymorphisms have been associated with both ADCC and clinical activity of trastuzumab in HER2+ breast cancer (BC) patients (pts). We analyzed FcγRIIa-H131R and FcγRIIIa-V158F polymorphisms in the CHER-LOB trial population of HER2+ BCs treated with preoperative chemotherapy plus trastuzumab (arm A), lapatinib (arm B) or both (arm C). Genotyping was successfully performed in 73/121 (60%) pts. A significant improvement in pathological complete response (pCR) rate was observed for the combination arm C, but only in FcγRIIIa V allele carriers (C vs A, 67 vs 27%, P=0.043; C vs B, 67 vs 22%, P=0.012). An independent interaction between arm C and FcγRIIIa V allele was found for pCR (odds ratio=9.4; 95% confidence interval, 2.3-39.6; P=0.003). No significant associations were observed between pCR and FcγRIIa polymorphism, and between pre-treatment tumor-infiltrating lymphocytes and FcγR polymorphisms. Our study provides evidence for a FcγRIIIa V allele-restricted pCR benefit from neoadjuvant trastuzumab plus lapatinib in HER2+ BC.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor , Neoplasias de la Mama/tratamiento farmacológico , Terapia Neoadyuvante , Variantes Farmacogenómicas , Polimorfismo de Nucleótido Simple , Inhibidores de Proteínas Quinasas/uso terapéutico , Quinazolinas/uso terapéutico , Receptor ErbB-2/análisis , Receptores de IgG/genética , Trastuzumab/uso terapéutico , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Neoplasias de la Mama/enzimología , Neoplasias de la Mama/genética , Neoplasias de la Mama/inmunología , Quimioterapia Adyuvante , Ensayos Clínicos Fase II como Asunto , Supervivencia sin Enfermedad , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Lapatinib , Mastectomía , Persona de Mediana Edad , Farmacogenética , Pruebas de Farmacogenómica , Fenotipo , Inhibidores de Proteínas Quinasas/efectos adversos , Quinazolinas/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Estudios Retrospectivos , Factores de Tiempo , Trastuzumab/efectos adversos , Resultado del Tratamiento
7.
Eur Ann Allergy Clin Immunol ; 47(5): 149-55, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26356999

RESUMEN

BACKGROUND: Cypresses play an important role in the urban landscape of the Mediterranean region, releasing a huge amount of allergenic airborne pollen which causes a specific pollinosis in exposed people. OBJECTIVE: The aim of this work is to evaluate, in vivo and in vitro, the potential allergenicity of Cupressus macrocarpa pollen, and to compare it with the allergenicity observed for C. arizonica and C. sempervirens. METHODS: Pollen extracts of the three species were prepared, to determine their protein profile through SDS PAGE analysis and to evaluate their allergenic potential through EAST inhibition assays and SPT. Pollen grain composition was evaluated using a cytochemical approach with optical microscopy. RESULTS: SDS PAGE, EAST inhibition and SPT indicated the higher allergenic potential of C. arizonica compared to C. sempervirens and C. macrocarpa. No significant differences in allergenic potential were found between the latter two species. Cytochemical observations reveal higher ß-glucans and protein content in the intine of C. arizonica during hydration. CONCLUSION: The higher protein content found in C. arizonica pollen grains extract may be due to higher enzyme activity leading to the movement of ß-glucans and pectins from the intine to the partially developed pollen cell wall during hydration. This could explain the higher potential allergenicity of C.arizonica in respect to C. macrocarpa and C. sempervirens.


Asunto(s)
Cupressus/inmunología , Extractos Vegetales/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/etiología , Adulto , Cupressus/química , Femenino , Histocitoquímica , Humanos , Masculino , Extractos Vegetales/análisis , Proteínas de Plantas/análisis , Polen/química
8.
Open Vet J ; 2(1): 19-22, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-26623286

RESUMEN

A 7-year-old Labrador Retriever female dog presenting left forelimb lameness for one day was admitted to the Veterinary Hospital (UNESP-Botucatu) for clinical evaluation. Several tests, including blood and image analysis, microbiological culture and cytology of lytic areas of affected bone were made in order to establish a diagnosis. Serum biochemical profile revealed increased levels of liver enzymes, plasma globulin, creatine kinase (CK) and calcium. Hemogram revealed anemia and leukocytosis; left humerus image analysis revealed an osteolytic lesion and cytology revealed a suppurative periostitis. Differential diagnosis was a nonspecific infectious inflammatory process or osteosarcoma. Since it was not possible to achieve a definitive diagnosis and there was a highly suspicious for an infectious agent, an agarose cell block of the bone marrow fine-needle aspiration was made. The cytological examination of cell block presented similar findings as described previously. However, additional stains including periodic acid-Schiff (PAS) were positive for fungal hyphae, which rendered a diagnosis of fungal osteomyelitis due to Aspergillus spp. This case report illustrates an uncommon cause of osteomyelitis for breed that was diagnosed by an underused method in veterinary medicine.

9.
Int Arch Allergy Immunol ; 145(3): 224-30, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-17914274

RESUMEN

BACKGROUND: Date palm (DP) pollen can cause allergic symptoms in people living in different countries. Specific immunotherapy with allergenic extracts by subcutaneous route is effective to cure allergic people. However, the risk of side effects has led to explore safer therapeutic modalities. The aim of our work was to evaluate IgE cross-reactivity between DP and autochthonous palm (European fan palm, EFP) pollen extracts, to chemically modify DP extract with potassium cyanate in order to obtain an allergoid, and to characterize it. METHODS: By radioallergosorbent test inhibition, immunoblotting (IB) and skin prick test, in vitro and in vivo allergenic activities of native and modified DP extracts were compared. By SDS-PAGE and IB, we compared the protein profile and IgE-binding capacity of both native and modified DP, as well as of EFP extracts. By IB inhibition, IgE cross-reactivity of native DP and EFP extracts was evaluated. By ELISA, the capacity of modified DP-induced IgG to react with native DP extract was determined. RESULTS: Radioallergosorbent test inhibition, IB and skin prick test results demonstrated that modified DP was significantly less allergenic than native DP extract. The SDS-PAGE profile showed that potassium cyanate treatment of DP extract did not alter the molecular weight of its components. In addition, no difference was observed between native DP and EFP extracts. Subsequent IB inhibition data evidenced the existence of a strong IgE cross-reactivity between native DP and EFP extracts. ELISA results indicated that the administration of modified DP in mice was able to induce specific IgG also recognizing native DP extract. CONCLUSIONS: Modified DP extract (allergoid) seems to be a good candidate for immunotherapy of patients affected by specific allergy.


Asunto(s)
Alérgenos/química , Alérgenos/inmunología , Arecaceae/inmunología , Hipersensibilidad/inmunología , Inmunoglobulina E/metabolismo , Extractos Vegetales/química , Extractos Vegetales/inmunología , Proteínas de Plantas/química , Proteínas de Plantas/inmunología , Polen/inmunología , Adulto , Alérgenos/efectos adversos , Alérgenos/efectos de los fármacos , Alérgenos/uso terapéutico , Alergoides , Animales , Especificidad de Anticuerpos , Arecaceae/efectos adversos , Cianatos/farmacología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Hipersensibilidad/sangre , Hipersensibilidad/etiología , Hipersensibilidad/terapia , Hipersensibilidad Inmediata/inducido químicamente , Immunoblotting , Inmunoglobulina E/inmunología , Inyecciones Subcutáneas , Masculino , Ratones , Ratones Endogámicos BALB C , Peso Molecular , Extractos Vegetales/efectos adversos , Extractos Vegetales/uso terapéutico , Proteínas de Plantas/efectos adversos , Proteínas de Plantas/efectos de los fármacos , Proteínas de Plantas/uso terapéutico , Polen/efectos adversos , Prueba de Radioalergoadsorción , Pruebas Cutáneas
10.
Allergol Immunopathol (Madr) ; 35(2): 74-5, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17428404

RESUMEN

Allergy to beet is very rare. Until now, only a few reports about asthma induced by inhaling the vapor of cooked beet have been published. We describe two patients with allergic rhinitis and positive skin prick tests to Parietaria and beet only. To investigate possible cross-reactivity between Parietaria pollen and beet, we performed laboratory assays that showed beet-specific IgE in the sera of both patients and possible cross-reactivity between Parietaria and beet in one patient.


Asunto(s)
Beta vulgaris/inmunología , Parietaria/inmunología , Especificidad de Anticuerpos , Reacciones Cruzadas , Humanos , Técnicas para Inmunoenzimas , Inmunoglobulina E/inmunología , Extractos Vegetales , Polen/inmunología , Estudios Retrospectivos
11.
Allergol. immunopatol ; 35(2): 74-75, mar. 2007. ilus, tab
Artículo en En | IBECS | ID: ibc-053809

RESUMEN

Allergy to beet is very rare. Until now, only a few reports about asthma induced by inhaling the vapor of cooked beet have been published. We describe two patients with allergic rhinitis and positive skin prick tests to Parietaria and beet only. To investigate possible cross-reactivity between Parietaria pollen and beet, we performed laboratory assays that showed beet-specific IgE in the sera of both patients and possible cross-reactivity between Parietaria and beet in one patient


No disponible


Asunto(s)
Humanos , Beta vulgaris/efectos adversos , Parietaria/efectos adversos , Polen/efectos adversos , Reacciones Cruzadas/inmunología , Hipersensibilidad a los Alimentos/inmunología
12.
Allergy ; 59(9): 1002-5, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15291910

RESUMEN

BACKGROUND: Exposure and contact with bee moth (Galleria mellonella) larvae (Gm) can cause an allergic reaction both in anglers and breeders. We described the case of an amateur fisherman who experienced an allergic reaction using Gm but not using heat-treated Gm (h-Gm) (mummies). The aim of this study was to demonstrate by immunoblotting and radioallergosorbent test (RAST)-inhibition experiments the loss of allergenic epitopes in h-Gm extracts. METHODS: Galleria mellonella larvae and h-Gm were homogenized and extracted at 10% (w/v) in 0.5 M phosphate-buffered saline, pH 7.4 containing 0.5% NaN(3) for 16 h at 4 degrees C. Gm and h-Gm extracts were electrophoresed in a 10% polyacrylamide precast Nupage Bis-Tris gel at 180 mA for 1 h and the resolved proteins stained with 0.1% Coomassie brilliant blue and the molecular weight calculated. For the immunoblotting detection of allergenic components the resolved extracts were transferred onto a nitrocellulose membrane and incubated with the patient's serum. Bound specific-IgE was detected by peroxidase-conjugated anti-human IgE. RAST inhibition experiments were performed according to the Ceska method. RESULTS: The protein profile of Gm and h-Gm extracts resulted markedly different in number, intensity and the position of bands, indicating that heat-treatment modifies the chemical-physical characteristics of the protein contents. The Gm extract showed a strong-coloured band at 73 kDa and more than 20 components ranging from 12 to 133 kDa; h-Gm showed two main band at 77 and 38 kDa and about 15 faint bands between 20 and 133 kDa apparently without any correspondence to the bands present in the Gm extract. Immunoblotting with the patient's serum demonstrated several bands of reactivity with the Gm extract ranging from 20 to 100 kDa and no recognizable bands, but only a diffuse smear with h-Gm. When used in a RAST inhibition experiment the h-Gm extract demonstrated an inability to compete with the Gm one for the binding to patient's IgE serum. CONCLUSIONS: The h-Gm seems to lose the allergenic epitopes and has two advantages for anglers: to avoid new possible sensitizations as well as allergic symptoms in sensitized people, without interfering with their skills and satisfaction in their fishing performance.


Asunto(s)
Antígenos/inmunología , Hipersensibilidad/etiología , Mariposas Nocturnas/inmunología , Adulto , Animales , Electroforesis en Gel de Poliacrilamida , Epítopos , Calor , Humanos , Immunoblotting , Larva/inmunología , Masculino , Peso Molecular , Prueba de Radioalergoadsorción
13.
Int Arch Allergy Immunol ; 129(4): 296-304, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12483034

RESUMEN

BACKGROUND: Cupressaceae (cypress) pollens can cause pollinosis in winter. However, the lack of specific commercial extracts combined with the early pollination period of cypress trees make a precise diagnosis difficult. The need for a reliable and effective cypress extract for diagnostic and therapeutic purposes is increasingly felt. METHODS: Mixed or single Cupressus arizonica, lusitanica and sempervirens pollen extracts precipitated with ammonium sulfate (PPT) were compared by direct RAST, RAST inhibition and SDS-PAGE techniques. The major allergen of C. arizonica (Cup a 1), purified by anion exchange chromatography, was checked by immunoblotting experiments before chemical modification, in parallel with a C. arizonica extract, with potassium cyanate (KCNO) to obtain a monomeric allergoid. The allergoid extract was characterized for its biological, chemico-physical and immunological features by RAST inhibition, SDS-PAGE and ELISA assays. RESULTS: Direct RAST, RAST inhibition, and SDS-PAGE data indicated that the PPT C. arizonica pollen extract showed the most allergenic potential, and it can be considered representative of the Cupressus spp. Immunoblotting data confirmed Cup a 1 as a major allergen. RAST inhibition and ELISA showed that modified PPT C. arizonica extract had less IgE reactivity than the native, non-modified extract, while preserving the immunogenic capacity typical for an allergoid. Finally, the SDS-PAGE profile of Cup a 1 allergoid was similar to native Cup a 1 allergen, suggesting the modified C. arizonica extract shows the characteristics of a monomeric allergoid. CONCLUSIONS: The PPT C. arizonica pollen extract shows good in vitro diagnostic potential and its chemically modified form offers the features of a monomeric allergoid. It might therefore lend itself to the development of a product to be administered by the sublingual or oromucosal route for immunotherapy of individuals with cypress pollinosis.


Asunto(s)
Alérgenos/aislamiento & purificación , Cupressus/inmunología , Proteínas de Plantas/aislamiento & purificación , Polen/inmunología , Especificidad de Anticuerpos , Antígenos de Plantas , Ensayo de Inmunoadsorción Enzimática , Humanos , Inmunoglobulina E/sangre , Técnicas In Vitro , Prueba de Radioalergoadsorción , Rinitis Alérgica Estacional/diagnóstico , Rinitis Alérgica Estacional/inmunología
14.
Allergy ; 51(1): 8-15, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8721522

RESUMEN

Allergenic extracts (Der p, grass, and Parietaria) or single allergens such as Par j I (the major allergen of Parietaria) and ovalbumin (OA), a food allergen widely used in animal models, were chemically modified by reaction with potassium cyanate (KCNO), which transforms the epsilon-amino group of the lysine of proteinaceous allergens into ureido groups. KCNO-modified (carbamylated) allergens have low allergenic potency, as demonstrated in vitro (RAST inhibition) and in vivo (passive cutaneous anaphylaxis). When used to immunize rabbits, carbamylated allergens still induce IgG antibodies able to cross-react with native allergens (immunoblotting experiments). An interesting feature distinguishing carbamylated allergens from other chemically modified allergens is the preservation of the native monomeric dimension as demonstrated by SDS-PAGE analysis. Results are discussed from the perspective of clinical application of carbamylated allergens.


Asunto(s)
Alérgenos/química , Alérgenos/inmunología , Cianatos/química , Animales , Immunoblotting , Inmunoglobulina E/biosíntesis , Ratones , Ratones Endogámicos BALB C , Anafilaxis Cutánea Pasiva , Conejos , Prueba de Radioalergoadsorción , Ratas , Ratas Sprague-Dawley , Vacunas Sintéticas
15.
J Immunol Methods ; 173(2): 181-90, 1994 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-8046253

RESUMEN

The potency of allergenic extracts can be determined in vitro by RAST inhibition, and this has become the preferred method for the standardization of allergens. A disadvantage of this technique is the impossibility of obtaining data about allergens bound to the solid phase, i.e., the counterpart of the inhibiting extract. The REAST (reverse enzyme allergosorbent test) is based on the capture of IgE by a specific antibody bound to microtiter wells, the reaction of captured IgE with biotinylated allergen and the development of a colour reaction by subsequent addition of streptavidin-peroxidase and chromogenic substrate. The addition of an allergen extract in a dose-response fashion competes with the biotinylated allergen and inhibits the test. In the present study REAST inhibition has been evaluated with Dermatophagoides pteronyssinus, Parietaria judaica and mixed grass pollen extracts. The correlation of REAST inhibition with RAST inhibition and both intra-assay and inter-assay reproducibility have been evaluated. REAST inhibition is a potentially valuable new tool for the standardization of allergenic extracts.


Asunto(s)
Alérgenos/inmunología , Técnicas para Inmunoenzimas , Animales , Unión Competitiva , Relación Dosis-Respuesta Inmunológica , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Ácaros/inmunología , Poaceae/inmunología , Polen/inmunología , Prueba de Radioalergoadsorción , Estándares de Referencia , Reproducibilidad de los Resultados
16.
Immunol Lett ; 40(1): 31-6, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7927511

RESUMEN

Polymerized allergens (allergoids) have been introduced in the immunotherapy of allergic disease in order to reduce the risk of side effects. However, their high molecular weight can be a limit, particularly when they are administered by a route involving passage through the mucosal barrier. We describe a simple procedure aimed at developing an original modified allergen with significantly less allergenic potential (intended as human IgE-binding capacity) but preserving the monomeric nature of the molecule. Par j I, the major allergen of Parietaria judaica pollen, was purified by a combination of monoclonal antibodies and affinity chromatography. Par j I allergen was then modified by reaction with potassium cyanate (KCNO), and compared with the native allergen to evaluate its allergenic potency (RAST-inhibition) and molecular weight (SDS-PAGE). Modified allergen showed significantly lower allergenic potency but kept its original molecular weight, making it particularly suitable for buccal (sublingual) administration. To study the adsorption profile, modified Par j I was radiolabeled and administered intravenously and sublingually to normal rats. The prospects for clinical application of the modified allergen are discussed.


Asunto(s)
Alérgenos/metabolismo , Glicoproteínas/metabolismo , Proteínas de Plantas , Polen/metabolismo , Absorción , Administración Sublingual , Alérgenos/aislamiento & purificación , Animales , Anticuerpos Monoclonales , Cromatografía de Afinidad , Glicoproteínas/aislamiento & purificación , Inmunoglobulina E/inmunología , Inyecciones Intravenosas , Masculino , Ratones , Ratones Endogámicos BALB C , Ratas , Ratas Sprague-Dawley
17.
Ophthalmology ; 100(4): 495-500, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8479706

RESUMEN

BACKGROUND: A patient's ability to control an intermittent exotropic deviation is usually assessed by subjective means such as observation of control in the office, questioning the patient and/or family about control at home, and reports of monocular eye closure in bright light. An objective method of assessing control has not been developed. PURPOSE: The purposes of this study are to determine if distance stereoacuity was different in patients with intermittent exotropia than in normal subjects and to determine if distance stereoacuity could be used as a objective means of assessing control in intermittent exotropia. METHODS: The authors evaluated near and distance stereoacuity in 44 patients with intermittent exotropia and 50 normal subjects. Patients with intermittent exotropia also were assessed for office control, home control, and monocular eye closure in bright light. Additionally, six patients who underwent successful surgery were reevaluated postoperatively. CONCLUSION: Normal subjects and patients with intermittent exotropia had good near stereoacuity. Patients with intermittent exotropia demonstrated significantly worse distance stereoacuity than the population of normal subjects (P < 0.001). Five of six patients with poor distance stereoacuity preoperatively had dramatic improvement in distance stereoacuity postoperatively. Diminished distance stereoacuity seems to be an objective measure of poor control of the exotropic deviation. This test may provide important objective criteria for deciding when to perform surgery in patients with intermittent exotropia.


Asunto(s)
Percepción de Distancia/fisiología , Exotropía/fisiopatología , Agudeza Visual/fisiología , Adolescente , Adulto , Niño , Preescolar , Exotropía/diagnóstico , Humanos , Persona de Mediana Edad
18.
Clin Pediatr (Phila) ; 31(5): 295-8, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1582096

RESUMEN

Although prophylactic eyedrops to treat ophthalmia neonatorum is mandated nationwide, states and hospitals are free to choose specific drugs. To compare two of these agents, we studied the incidence and characteristics of ophthalmia neonatorum in two UCLA teaching hospitals over a five-year period. One, which used 1% silver nitrate solution exclusively, had 50 cases in 34,772 births, a frequency of 0.14%. The other used 0.5% erythromycin ointment exclusively and had 43 cases in 12,652 births, a frequency of 0.34%. Ophthalmia neonatorum was more frequent in the hospital using erythromycin (p less than 0.001), as was chlamydial conjunctivitis (p less than 0.02). Although not statistically significant, gonococcal conjunctivitis was found in four infants, all in the hospital using silver nitrate. Because silver nitrate was found more effective in decreasing the total frequency of all cases of ophthalmia neonatorum, and cases caused by Chlamydia and gram-negative bacteria specifically, this drug still should be considered as a primary prophylactic agent against ophthalmia neonatorum.


Asunto(s)
Infecciones por Chlamydia/prevención & control , Chlamydia trachomatis , Conjuntivitis Bacteriana/prevención & control , Eritromicina/uso terapéutico , Oftalmía Neonatal/prevención & control , Nitrato de Plata/uso terapéutico , Bacterias/aislamiento & purificación , Infecciones por Chlamydia/microbiología , Chlamydia trachomatis/aislamiento & purificación , Conjuntivitis Bacteriana/microbiología , Humanos , Recién Nacido , Oftalmía Neonatal/microbiología , Estudios Retrospectivos
19.
J Pediatr Ophthalmol Strabismus ; 28(5): 255-60, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1955959

RESUMEN

A new standardized method for evaluating distance stereo acuity has been developed, using the graphic capacity of a high-frequency microprocessor and liquid crystal binocular glasses. Images are alternately presented at a frequency of 60 cycles per second to each eye, using synchronized liquid crystal shutter glasses. The amount of disparity in the stereo patterns can be altered to allow a measurement as refined as 15 seconds of arc ("). This instrument is now commercially available as part of the Mentor B-Vat system. We evaluated distance Random Dot and Contour circle stereo acuity of 50 normal subjects using this new method and compared these results to conventional Titmus and Randot circles at near. The distance stereo acuity mean results were 139" for the Random Dot test and 41.1" for the Contour circles. The near stereo acuity results were 41.8" for the Titmus circles and 27" for the Randot circles. Statistically, the Titmus results at near can be compared to the Contour circles at distance. The distance Random Dot test results demonstrate much less stereoability than the other test. The application of these new distance stereotests will be discussed.


Asunto(s)
Percepción de Profundidad , Pruebas de Visión/métodos , Agudeza Visual , Adolescente , Adulto , Niño , Esotropía/diagnóstico , Esotropía/fisiopatología , Exotropía/diagnóstico , Exotropía/fisiopatología , Humanos , Persona de Mediana Edad , Pruebas de Visión/instrumentación
20.
Arch Ophthalmol ; 103(10): 1507-9, 1985 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2413832

RESUMEN

Few studies comment on the type of refractive errors found in patients with Leber's congenital amaurosis. The association of an uncomplicated infantile form of this condition with high hyperopia but without systemic complications has been suggested. In a retrospective study, we identified 11 patients who satisfied the criteria for the diagnosis of this subtype of Leber's congenital amaurosis. All of our cases were found to have at least +6.00 diopters of hyperopia on cycloplegic refraction. No systemic abnormalities were found in any of these children. We suggest that high hyperopia be included in the diagnostic criteria of this specific form of Leber's congenital amaurosis.


Asunto(s)
Ceguera/congénito , Hiperopía/complicaciones , Ceguera/complicaciones , Ceguera/diagnóstico , Discapacidades del Desarrollo/complicaciones , Electrorretinografía , Femenino , Gonioscopía , Humanos , Lactante , Masculino , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...